|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 16/28 | |
| A01K 67/027 | |||
| A61K 39/395 | |||
| A61K 31/4745 | |||
| A61K 31/513 | |||
| A61K 31/522 | |||
| A61K 39/00 |
| (11) | Number of the document | 2956484 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14732006.3 |
| Date of filing the European patent application | 2014-02-13 | |
| (97) | Date of publication of the European application | 2015-12-23 |
| (45) | Date of publication and mention of the grant of the patent | 2018-11-14 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/IB2014/000867 |
| Date | 2014-02-13 |
| (87) | Number | WO 2014/125382 |
| Date | 2014-08-21 |
| (30) | Number | Date | Country code |
| 201361764446 P | 2013-02-13 | US |
| (72) |
MEADE, Harry, M., US
|
| (73) |
Laboratoire Franēais du Fractionnement et des Biotechnologies,
3, Avenue des Tropiques ZA de Courtaboeuf, 91940 Les Ulis,
FR
|
| (54) | CETUXIMAB WITH MODIFIED GLYCOSYLATION AND USES THEREOF |
| CETUXIMAB WITH MODIFIED GLYCOSYLATION AND USES THEREOF |